The expression of TFIIIB components BRF1, BRF2 and BDP1 was in tendency higher in luminal subtypes, that of most TFIIIC components (C2-C6) in Her2-overexpressing cancer, but none of these general Pol III transcription factors showed increased expression levels in basal breast cancers. This evidence concerns the gene ERBB2 and cancer.